In vivo neutralization of botulinum neurotoxins serotype E with heavy-chain camelid antibodies (VHH).
about
Random mutagenesis of BoNT/E Hc nanobody to construct a secondary phage-display library.A heterodimer of a VHH (variable domains of camelid heavy chain-only) antibody that inhibits anthrax toxin cell binding linked to a VHH antibody that blocks oligomer formation is highly protective in an anthrax spore challenge model.A novel nanobody specific for respiratory surfactant protein A has potential for lung targeting.Cargo-delivery platforms for targeted delivery of inhibitor cargos against botulism.Production of Novel VHH Nanobody Inhibiting Angiogenesis by Targeting Binding Site of VEGF.Inhibition of the Myotoxicity Induced by Bothrops jararacussu Venom and Isolated Phospholipases A2 by Specific Camelid Single-Domain Antibody Fragments.Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display.Generation of Recombinant Antibodies Against Toxins and Viruses by Phage Display for Diagnostics and Therapy.Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin EChallenges in searching for therapeutics against Botulinum Neurotoxins.The European AntibotABE Framework Program and Its Update: Development of Innovative Botulinum Antibodies.Functional mutations in and characterization of VHH against Helicobacter pylori urease.Expression of single-domain antibody in different systems.A Three Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotype E Subtypes.Camelid-derived heavy-chain nanobody against Clostridium botulinum neurotoxin E in Pichia pastoris.Targeting Colorectal Cancer Cell Lines Using Nanobodies; AgSK1as a Potential Target.
P2860
Q35157493-CC0C36D6-A26E-43A4-A20C-D36793E52A6DQ35173029-8AACF892-3AD7-411A-9FF8-59E70BF1B29BQ35491484-D02E33BE-15D7-4A28-A470-E0674F90C0F1Q35542237-D2BEB18A-BC3D-41D9-A552-02717B01F1BAQ35657061-66696AF2-6ECC-4D0F-B379-D7A114971B10Q35974249-97D93B4C-17C2-4198-BE9A-4285B4F16588Q36023082-C8A966C6-FF67-4784-B9AF-6AAAC521AA2AQ36033286-70DEE999-1514-44E5-8A84-54C1FF49BAB2Q36126718-A57F8079-F489-4FCB-92F3-B3684CAE28AAQ39167871-48332AEF-45B0-4E99-A760-EAA71576029FQ45235847-512243EF-F9AD-449A-A4C4-EC496CB0C343Q45265906-FFEE73AB-AE90-47A9-85F6-393D098E50C5Q47312316-D20B01F9-9FB4-40F9-8450-AB9C0CE4BFDCQ52679598-9E545300-9917-43A0-B7F9-58B29E92DF83Q54292251-D98329B3-E307-450B-A73F-00941D5A63B9Q55318053-CD048350-BF0D-403F-8C12-B10BC6F75781
P2860
In vivo neutralization of botulinum neurotoxins serotype E with heavy-chain camelid antibodies (VHH).
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
In vivo neutralization of botu ...... hain camelid antibodies (VHH).
@ast
In vivo neutralization of botu ...... hain camelid antibodies (VHH).
@en
In vivo neutralization of botu ...... heavy-chain camelid antibodies
@nl
type
label
In vivo neutralization of botu ...... hain camelid antibodies (VHH).
@ast
In vivo neutralization of botu ...... hain camelid antibodies (VHH).
@en
In vivo neutralization of botu ...... heavy-chain camelid antibodies
@nl
prefLabel
In vivo neutralization of botu ...... hain camelid antibodies (VHH).
@ast
In vivo neutralization of botu ...... hain camelid antibodies (VHH).
@en
In vivo neutralization of botu ...... heavy-chain camelid antibodies
@nl
P2093
P2860
P50
P1476
In vivo neutralization of botu ...... chain camelid antibodies (VHH)
@en
P2093
Hamid Bakherad
Leila Safaee Ardakani
Mohammad Mohammadi
Walead Ebrahimizadeh
P2860
P2888
P304
P356
10.1007/S12033-013-9669-1
P577
2013-10-01T00:00:00Z